Cited by 342Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAdvanced MRI Techniques and Applications

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

19F and 1H MRI detection of amyloid β plaques in vivo

Higuchi, Makoto, Iwata, Nobuhisa, Matsuba, Yukio, Sato, Kumi, Sasamoto, Kazumi, Saido, Takaomi C·2005·Nature Neuroscience

DOI 10.1038/nn1422

Open this paper in CoChat — free account

Abstract

Formation of senile plaques composed of amyloid beta peptide, a pathological hallmark of Alzheimer disease, in human brains precedes disease onset by many years. Noninvasive detection of such plaques could be critical in presymptomatic diagnosis and could contribute to early preventive treatment strategies. Using amyloid precursor protein (APP) transgenic mice as a model of amyloid beta amyloidosis, we demonstrate here that an intravenously administered (19)F-containing amyloidophilic compound labels brain plaques and allows them to be visualized in living mice by magnetic resonance imaging (MRI) using (19)F and (1)H. Our findings provide a new direction for specific noninvasive amyloid imaging without the danger of exposure to radiation. This approach could be used in longitudinal studies in mouse models of Alzheimer disease to search for biomarkers associated with amyloid beta pathology as well as to track disease course after treatment with candidate medications.

Integrity signals

Registry

Crossref · 10.1038/nn1422

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
RARE imaging: A fast imaging method for clinical MR
Hennig, J., Nauerth, A., & Friedburg, H. (1986) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910030602 · Cited by 2,088
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1×
“Although plaques by themselves may not be a direct cause of Alzheimer disease symptoms, a noninvasive method to detect them in the brain will allow diagnosis and preventive treatment of affected individuals before neurological symptoms and irreversible neurodegeneration occu”
Method
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Localization of Neurofibrillary Tangles and Beta-Amyloid Plaques in the Brains of Living Patients With Alzheimer Disease
Shoghi, K. I., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., Read, S., Satyamurthy, N., Petrič, A., Huang, S., et al. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00004 · Cited by 774
Alzheimer's Disease: A Central Role for Amyloid
Selkoe, D. J. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00003 · Cited by 752
Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”
The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association and, & National Institute on Aging Working Group (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00022-0 · Cited by 719
Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques
Saido, T. C., Iwatsubo, T., Mann, D. M. A., Shimada, H., Ihara, Y., & Kawashima, S. (1995) · Neuron · doi:10.1016/0896-6273(95)90301-1 · Cited by 587

Flagged first, then by citations

Show all 32 references

Sorted by citations

Items 201–300 of 342

Compounds for imaging amyloid-β deposits in an Alzheimer’s brain: a patent review
Tu, P.-Y., Fu, H.-L., & Cui, M. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1007953 · Cited by 19
Fluorine-modified bisbenzimide derivative as a molecular probe for bimodal and simultaneous detection of DNAs by 19 F NMR and fluorescence
Sakamoto, T., Hasegawa, D., & Fujimoto, K. (2015) · Chemical Communications · doi:10.1039/c5cc01995h · Cited by 19
Non‐Invasive Physiology and Pharmacology Using 19F Magnetic Resonance
Yu, J., Cui, W., Zhao, D., & Mason, R. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-444-53086-8.00005-9 · Cited by 19
Development of Molecular Imaging Tools to Investigate Protein Functions by Chemical Probe Design
Mizukami, S. (2011) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.59.1435 · Cited by 19
Synthesis and Biological Evaluation of Curcumin Analogs as β-Amyloid Imaging Agents
Gan, C., Hu, J., Nan, D., Wang, S., & Li, H. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0079 · Cited by 19
Alzheimer disease, in living color
Small, S. A. (2005) · Nature Neuroscience · doi:10.1038/nn0405-404 · Cited by 19
Unveiling Molecular Events in the Brain by Noninvasive Imaging
Klohs, J., & Rudin, M. (2011) · The Neuroscientist · doi:10.1177/1073858410383433 · Cited by 22
Synthesis and evaluation as MRI probe of the trifluoromethylated p-boronophenylalanine and its alcohol derivative
Hattori, Y., Yamamoto, H., Ando, H., Kondoh, H., Asano, T., Kirihata, M., Yamaguchi, Y., & Wakamiya, T. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.12.043 · Cited by 18
Polyfluorinated bis-styrylbenzenes as amyloid-β plaque binding ligands
Nabuurs, R. J. A., Kapoerchan, V. V., Metaxas, A., de Jongh, S., de Backer, M., Welling, M. M., Jiskoot, W., Windhorst, A. D., Overkleeft, H. S., van Buchem, M. A., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.02.054 · Cited by 18
Novel methods for detecting amyloidogenic proteins in transthyretin related amyloidosis
Ando, Y. (2008) · Frontiers in bioscience · doi:10.2741/3098 · Cited by 18
Imaging in cell-based therapy for neurodegenerative diseases
Kirik, D., Breysse, N., Björklund, T., Besret, L., & Hantraye, P. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1909-6 · Cited by 18
The simple preparation of polyethylene glycol-based soft nanoparticles containing dual imaging probes
Murayama, S., Jo, J.-I., Shibata, Y., Liang, K., Santa, T., Saga, T., Aoki, I., & Kato, M. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20828a · Cited by 17
Rational Design, Synthesis of Fluorescence Probes for Quantitative Detection of Amyloid-β in Alzheimer’s Disease Based on Rhodamine-Metal Complex
Xiang, J., Xiang, C., Zhou, L., Sun, M., Feng, L., Liu, C., Cai, L., & Gong, P. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c01911 · Cited by 17
Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers
Bisi, N., Pinzi, L., Rastelli, G., & Tonali, N. (2024) · Molecules · doi:10.3390/molecules29030722 · Cited by 17
Construction of a 19F-lectin biosensor for glycoprotein imaging by using affinity-guided DMAP chemistry
Sun, Y., Takaoka, Y., Tsukiji, S., Narazaki, M., Matsuda, T., & Hamachi, I. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.038 · Cited by 17
Emergence of breath testing as a new non-invasive diagnostic modality for neurodegenerative diseases
Subramaniam, N. S., Bawden, C. S., Waldvogel, H. J., Faull, R. L. M., Howarth, G. S., & Snell, R. G. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.017 · Cited by 17
Inhalable Thioflavin S for the Detection of Amyloid Beta Deposits in the Retina
Barton, S. M., To, E. C., Rogers, B. P., Whitmore, C. A., Uppal, M., Matsubara, J. A., & Pham, W. N. (2021) · Molecules · doi:10.3390/molecules26040835 · Cited by 17
Hyperpolarized Xenon-129 Chemical Exchange Saturation Transfer (HyperCEST) Molecular Imaging: Achievements and Future Challenges
Batarchuk, V., Shepelytskyi, Y., Grynko, V., Kovacs, A. H., Hodgson, A., Rodriguez, K., Aldossary, R., Talwar, T., Hasselbrink, C. L., Ruset, I. C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031939 · Cited by 16
Experimental approaches to assess metallotoxicity and ageing in models of Alzheimer's disease
Platt, B. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-102-307 · Cited by 16
Die Amyloid‐Kongorot‐Bindungsstelle in atomarer Auflösung
Schütz, A. K., Soragni, A., Hornemann, S., Aguzzi, A., Ernst, M., Böckmann, A., & Meier, B. H. (2011) · Angewandte Chemie · doi:10.1002/ange.201008276 · Cited by 16
Study on the compounds containing 19F and 10B atoms in a single molecule for the application to MRI and BNCT
Hattori, Y., Asano, T., Niki, Y., Kondoh, H., Kirihata, M., Yamaguchi, Y., & Wakamiya, T. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.10.062 · Cited by 15
In Vivo Imaging Biomarkers in Mouse Models of Alzheimer's Disease: Are We Lost in Translation or Breaking Through?
Delatour, B., Epelbaum, S., Petiet, A., & Dhénain, M. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/604853 · Cited by 18
Fluorinated Molecules in the Diagnosis and Treatment of Neurodegenerative Diseases
Gaye, B., & Adejare, A. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.85 · Cited by 14
Discovery of boronic acid-based fluorescent probes targeting amyloid-beta plaques in Alzheimer’s disease
Jung, S.-J., Lee, J., Kim, T. H., Lee, D., Jeon, J., Yang, S. D., Hur, M. G., Min, J., & Park, Y. D. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.02.042 · Cited by 14
High-Affinity Fluorescent Probes for the Detection of Soluble and Insoluble Aβ Deposits in Alzheimer’s Disease
Mallesh, R., Khan, J., Gharai, P. K., Ghosh, S., Garg, S., Arshi, M. U., & Ghosh, S. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00787 · Cited by 14
AFM and TEM observations of -helix to -sheet conformational change occurring on carbon nanotubes
Sugiyama, Y. (2006) · Journal of Electron Microscopy · doi:10.1093/jmicro/dfl024 · Cited by 14
Prospects for Early Detection of Alzheimers Disease from Serial MR Images in Transgenic Mouse Models
Muskulus, M., Scheenstra, A. E. H., Braakman, N., Dijkstra, J., Lunel, S. M. V., Alia, A., de Groot, H. J. M., & Reiber, J. H. C. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147089 · Cited by 14
The Congo red derivative FSB binds to curli amyloid fibers and specifically stains curliated E. coli
Reichhardt, C., & Cegelski, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203226 · Cited by 14
A Versatile Approach to β-Amyloid Fibril-Binding Compounds Exploiting the Shirakawa/Hayashi Protocol for trans-Alkene Synthesis
Huynh, T. H. V., Mantel, M. L. H., Mikkelsen, K., Lindhardt, A. T., Nielsen, N. C., Otzen, D. E., & Skrydstrup, T. (2009) · Organic Letters · doi:10.1021/ol8029593 · Cited by 14
Thermoresponsive Triblock Copolymers as Widely Applicable 19F Magnetic Resonance Imaging Tracers
Kolouchová, K., Groborz, O., Šlouf, M., Herynek, V., Parmentier, L., Babuka, D., Černochová, Z., Koucký, F., Sedláček, O., Hrubý, M., et al. (2022) · Chemistry of Materials · doi:10.1021/acs.chemmater.2c02589 · Cited by 13
Fluorine-19 Magnetic Resonance Imaging for Detection of Amyloid β Oligomers Using a Keto Form of Curcumin Derivative in a Mouse Model of Alzheimer’s Disease
Yanagisawa, D., Ibrahim, N. F., Taguchi, H., Morikawa, S., Tomiyama, T., & Tooyama, I. (2021) · Molecules · doi:10.3390/molecules26051362 · Cited by 13
Nanoimaging in Protein-Misfolding And -Conformational Diseases
Uversky, V. N. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.615 · Cited by 13
Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: The do's and don't's
den Adel, B., Bovens, S. M., Boekhorst, B. C. M. T., Strijkers, G. J., Poelmann, R. E., van der Weerd, L., & Pasterkamp, G. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.07.028 · Cited by 12
MR−Based Molecular Imaging of the Brain: The Next Frontier
de Backer, M. E., Nabuurs, R. J. A., van Buchem, M. A., & van der Weerd, L. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2264 · Cited by 12
La Lunga Attesa : Towards a Molecular Approach to Neuroimaging and Therapeutics in Alzheimer's Disease
Villemagne, V. L., Ng, S., Cappai, R., Barnham, K. J., Fodero‐Tavoletti, M. T., Rowe, C. C., & Masters, C. L. (2006) · The Neuroradiology Journal · doi:10.1177/197140090601900406 · Cited by 12
8C-6 Anisotropic Viscoelastic Properties of the Corpus Callosum - Application of High-Resolution 3D MR-Elastography to an Alzheimer Mouse Model
Larrat, B., Chan, Q., Yang, X., Li, G., Yang, E. S., Fink, M., & Sinkus, R. (2007) · Proceedings/Proceedings - IEEE Ultrasonics Symposium · doi:10.1109/ultsym.2007.175 · Cited by 12
Age-dependent microstructure alterations in 5xFAD mice by high-resolution diffusion tensor imaging
Maharjan, S., Tsai, A. P., Lin, P. B., Ingraham, C., Jewett, M. R., Landreth, G. E., Oblak, A. L., & Wang, N. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.964654 · Cited by 15
“The plaques showed hypointensity in MRI images and increased with age in both cortex and hippocampus regions, which is consistent with several previous findings (Higuchi et al., 2005; Meadowcroft et al., 2009).”
Result
Amyloid‑β guided responsive theranostic fluorescent probe for imaging of endogenous hydrogen peroxide in Alzheimer disease
Yang, Y., Wang, C., Xue, H., Chen, P., Li, H., & Wong, M. S. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.135452 · Cited by 11
A mitochondria targeting, de novo designed, aggregation-induced emission probe for selective detection of neurotoxic amyloid-β aggregates
Bera, T., Mondal, A., Kar, S., Mukherjee, A., Banerjee, S., & Guha, S. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01337a · Cited by 11
Multiresponsive fluorinated polymers as a theranostic platform using 19F MRI
Kolouchová, K., Černochová, Z., Groborz, O., Herynek, V., Koucký, F., Jakša, R., Beneš, J., Šlouf, M., & Hrubý, M. (2022) · European Polymer Journal · doi:10.1016/j.eurpolymj.2022.111381 · Cited by 11
Bringing amyloid into focus
Golde, T. E., & Bacskai, B. J. (2005) · Nature Biotechnology · doi:10.1038/nbt0505-552 · Cited by 11
Exploiting the Fluxionality of Lanthanide Complexes in the Design of Paramagnetic Fluorine Probes
Wilharm, R. K., Raju, M. V. R., Hoefler, J. C., Platas‐Iglesias, C., & Pierre, V. C. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.1c03908 · Cited by 11
Fluorine depth profiling by high-resolution 1D magnetic resonance imaging
Dikic, T., Erich, S. J. F., Ming, W., Huinink, H., Thüne, P. C., van Benthem, R. A. T. M., & de With, G. (2007) · Polymer · doi:10.1016/j.polymer.2007.05.017 · Cited by 11
Fluorine‐19 magnetic resonance imaging probe for the detection of tau pathology in female rTg4510 mice
Yanagisawa, D., Ibrahim, N. F., Taguchi, H., Morikawa, S., Kato, T., Hirao, K., Shirai, N., Sogabe, T., & Tooyama, I. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24188 · Cited by 11
Rapid detection of Aβ deposits in APP transgenic mice by Hoechst 33342
Uchida, Y., & Takahashi, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.052 · Cited by 11
An Expedient Synthesis of the Fibril Binding Compound FSB via Sequential Pd-Catalyzed Coupling Reactions
Mantel, M. L. H., Søbjerg, L. S., Huynh, T. H. V., Ebran, J., Lindhardt, A. T., Nielsen, N. C., & Skrydstrup, T. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo7026189 · Cited by 11
Emerging biology of the cholinergic system across the spectrum of Alzheimer’s disease
Nordberg, A. K. (2006) · International Psychogeriatrics · doi:10.1017/s1041610206003991 · Cited by 11
Novel 18F-labeled dibenzylideneacetone derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques
Li, Z., Cui, M., Zhang, J., Dai, J., Zhang, X., Peng, C., Jia, H., & Liu, B. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.070 · Cited by 10
Pre-clinical optical imaging and MRI for drug development in Alzheimer's disease
Rotman, M., Snoeks, T. J. A., & van der Weerd, L. (2011) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2011.11.005 · Cited by 10
Transcranial in vivo detection of amyloid-beta at single plaque resolution with large-field multifocal illumination fluorescence microscopyPreprint
Ni, R., Chen, Z., Shi, G., Villois, A., Zhou, Q., Arosio, P., Nitsch, R. M., Nilsson, K. P. R., Klohs, J., & Razansky, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.01.929844 · Cited by 10
Advances and future trends in the detection of beta-amyloid: A comprehensive review
Ganguly, A., Babu, S. S., Ghosh, S. K., Velyutham, R., & Kapusetti, G. (2024) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2024.104269 · Cited by 9
Whatever Happened to Pittsburgh Compound-A?
Klunk, W. E., & Mathis, C. A. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318188c0c8 · Cited by 9
Simultaneous detection of single-nucleotide polymorphisms in a DNA bulge structure using a fluorine-modified bisbenzimide derivative
Sakamoto, T., Hasegawa, D., & Fujimoto, K. (2015) · The Analyst · doi:10.1039/c5an02389k · Cited by 9
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients
Tasaki, M., Milani, P., Foli, A., Verga, L., Obici, L. P., Basset, M., Bozzola, M., Ferraro, G., Nuvolone, M., Morbini, P., et al. (2019) · Blood · doi:10.1182/blood.2019000420 · Cited by 9
Multi‐fluorine labeled indanone derivatives as potential MRI imaging probes for β‐Amyloid plaques
Dai, Y., Fang, T., Xu, Y., Jiang, T., & Qiao, J. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14162 · Cited by 9
In vivo 19-fluorine magnetic resonance imaging
Staal, X., Koshkina, O., & Srinivas, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812733-9.00011-8 · Cited by 9
Advances in nanoprobes for molecular MRI of Alzheimer's disease
Parekh, P. A., Badachhape, A., Tanifum, E. A., Annapragada, A., & Ghaghada, K. B. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1946 · Cited by 9
Fluorescent Styryl Dyes from 4-Chloro-2-(Diphenylamino)-1, 3-Thiazole-5-Carbaldehyde—Synthesis, Optical Properties and TDDFT Computations
Sekar, N., Umape, P. G., & Patil, S. R. (2015) · Journal of Fluorescence · doi:10.1007/s10895-015-1668-0 · Cited by 8
A 19 F-MRI probe for the detection of Fe( ii ) ions in an aqueous system
Kakiuchi, R., Hirayama, T., Yanagisawa, D., Tooyama, I., & Nagasawa, H. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob00903b · Cited by 8
Fluorinated [2]rotaxanes as sensitive 19F MRI agents: Threading for higher sensitivity
Yang, L., Li, Y., Jiang, M., Zhou, R., Cong, H., Yang, M., Zhang, L., Li, S., Yang, Y., Liu, M., et al. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.109512 · Cited by 7
Novel pyrrolidine-alkylamino-substituted dicyanoisophorone derivatives as near-infrared fluorescence probe for imaging β-amyloid in vitro and in vivo
Zhou, H., Zhai, J., Gong, H., Fang, R., Zhao, Y., & Luo, W. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.342894 · Cited by 7
Molecular Design of Magnetic Resonance Imaging Agents Binding to Amyloid Deposits
Nikiforova, A. A., & Sedov, I. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311152 · Cited by 7
Different Permeability of Potassium Salts across the Blood-Brain Barrier Follows the Hofmeister Series
Breschi, G. L., Cametti, M., Mastropietro, A., Librizzi, L., Baselli, G., Resnati, G., Metrangolo, P., & de Curtis, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078553 · Cited by 7
Molecular Imaging in Alzheimer's Disease
Lascola, C. D. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.006 · Cited by 7
Bis-pyridylethenyl benzene as novel backbone for amyloid-β binding compounds
Nabuurs, R. J. A., Kapoerchan, V. V., Metaxas, A., Hafith, S., de Backer, M., Welling, M. M., Jiskoot, W., van den Nieuwendijk, A. M. C. H., Windhorst, A. D., Overkleeft, H. S., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.022 · Cited by 7
Fluorodopa is a Promising Fluorine‐19 MRI Probe for Evaluating Striatal Dopaminergic Function in a Rat Model of P arkinson's Disease
Yanagisawa, D., Oda, K., Inden, M., Morikawa, S., Inubushi, T., Taniguchi, T., Hijioka, M., Kitamura, Y., & Tooyama, I. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23983 · Cited by 7
Molecular fMRI
Hai, A., & Jasanoff, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00013-0 · Cited by 7
Neuroimaging in Alzheimer's disease: preclinical challenges toward clinical efficacy
Dustin, D. J., Hall, B. M., Annapragada, A., & Pautler, R. G. (2016) · Translational research · doi:10.1016/j.trsl.2016.03.005 · Cited by 7
MRI in Dementia
Schmidt, R., Havas, D., Ropele, S., Enzinger, C., & Fazekas, F. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.09.003 · Cited by 7
Ligation driven 19 F relaxation enhancement in self-assembled Ln( iii ) complexes
Davies, G., Brown, A., Blackburn, O. A., Tropiano, M., Faulkner, S., Beer, P. D., & Davis, J. J. (2014) · Chemical Communications · doi:10.1039/c4cc09952d · Cited by 6
Network activity changes in the pathophysiology of Alzheimer’s disease: the role of aging and early entorhinal cortex dysfunction
Setti, S. E., & Reed, M. N. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00848-8 · Cited by 7
High-Resolution and Microscopic Imaging at High Field
Wald, L. L., Fischl, B. R., & Rosen, B. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-49648-1_11 · Cited by 6
Recent Advances in Visualizing Alzheimer's Plaques by Magnetic Reso- nance Imaging
Braakman, N., van Buchem, M., Schliebs, R., de Groot, H. D., & Alia, A. (2009) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/157340509787354741 · Cited by 5
In Vivo Mouse Imaging and Spectroscopy in Drug Discovery
Beckmann, N., Cannet, C., Rausch, M., Kneuer, R., & Gremlich, H. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0134-7_15 · Cited by 6
Statistical analysis for longitudinal MR imaging of dementia
Ridgway, G. R. (2009) · UCL Discovery (University College London) · Cited by 6
Sensitive Multichannel 19F Magnetic Resonance Imaging Enabled by Paramagnetic Fluorinated Ionic Liquid-Based Probes
Chen, L., Jiang, Y., Xiong, N., Fan, Y., Lin, H., & Gao, J. (2025) · ACS Nano · doi:10.1021/acsnano.4c17959 · Cited by 5
Oral administration of arginine suppresses Aβ pathology in animal models of Alzheimer's disease
Fujii, K., Takeuchi, T., Fujino, Y., Tanaka, N., Fujino, N., Takeda, A., Minakawa, E. N., & Nagai, Y. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106082 · Cited by 6
High-Sensitivity, Low-Field 19F-MRI Approach Using High Manganese Ferrite Concentrations
Cao, Y., Zhou, X., Liu, X., Yang, M., Liu, W., & Han, D. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c00379 · Cited by 5
Alzheimer’s disease
Gazzaley, A. H., & Small, S. A. (2011) · Network Computation in Neural Systems · doi:10.3109/0954898x.2011.638696 · Cited by 5
Novel styrylbenzene derivatives for detecting amyloid deposits
Nakazono, M., Obayashi, K., Sasamoto, K., Tomiyoshi, K., Suenaga, G., & Ando, Y. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.04.028 · Cited by 5
Animal models of tauopathies
Higuchi, M., Saido, T. C., & Suhara, T. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00685.x · Cited by 5
18F-Labeled benzylideneaniline derivatives as new ligands for β-amyloid plaque imaging in Alzheimer's disease
Lee, H. J., Jeong, J. M., Rai, G., Lee, Y., Chang, Y. S., Kim, Y. J., Kim, H. W., Lee, D. S., Chung, J.-K., Mook‐Jung, I., et al. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.11.004 · Cited by 5
Neprilysin-sensitive amyloidogenic Aβ versus IDE-sensitive soluble Aβ: a probable mechanistic cause for sporadic Alzheimer’s diseasePreprint
Sasaguri, H., Takamura, R., Watamura, N., Kakiya, N., Ohshima, T., Fujioka, R., Yamazaki, N., Sekiguchi, M., Iwata, K., Matsuba, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.22.457281 · Cited by 5
Unsymmetric indolylmaleimides: Synthesis, photophysical properties and amyloid detection
Nakazono, M., Obayashi, K., Oshikawa, Y., Tani, K., Suenaga, G., Ando, Y., Nanbu, S., & Kuwano, R. (2014) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2014.04.027 · Cited by 4
Preclinical MRI and NMR Biomarkers of Alzheimer's Disease: Concepts and Applications
Dhénain, M. (2008) · Magnetic Resonance Insights · doi:10.4137/mri.s971 · Cited by 4
A β-Amyloid(1-42) Biosensor Based on Molecularly Imprinted Poly-Pyrrole for Early Diagnosis of Alzheimer’s Disease
Vais, R. D., Yadegari, H., Heli, H., & Sattarahmady, N. (2021) · Journal of Biomedical Physics and Engineering · doi:10.31661/jbpe.v0i0.1070 · Cited by 4
Multimodal methods to study protein aggregation and fibrillation
Herrera, M. G., Giampà, M., Tonali, N., & Dodero, V. I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90264-9.00006-4 · Cited by 4
Fluorine-19 Fast Recovery Fast Spin Echo Imaging for Mapping 5-Fluorouracil
Morikawa, S., Inubushi, T., Morita, M., Murakami, K., Masuda, C., Maki, J., & Tooyama, I. (2007) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.6.235 · Cited by 4
Cien años de la enfermedad de Alzheimer: La inmunoterapia ¿una esperanza?
Behrens, M. I., & Fernando Vergara, E. (2007) · Revista médica de Chile · doi:10.4067/s0034-98872007000100015 · Cited by 4
Quantification of amyloid deposits and oxygen extraction fraction in the brain with multispectral optoacoustic imaging in arcAbeta mouse model of Alzheimer's disease
Klohs, J., Vaas, M., Rudin, M., & Ni, R. (2018) · Photons Plus Ultrasound: Imaging and Sensing · doi:10.1117/12.2286309 · Cited by 3
Chapter 2 Advanced Detection Techniques and Hardware: Simultaneous19F/1 H MRI
Hu, L., Keupp, J., Caruthers, S. D., Goette, M., Lanza, G. M., & Wickline, S. A. (2016) · Pan Stanford Publishing eBooks · doi:10.1201/9781315364605-3 · Cited by 3
In Vivo Imaging Applications for the Nervous System in Animal Models
Gabrielson, K. L., Fletcher, C., Czoty, P. W., Nader, M. A., & Gluckman, T. L. (2011) · Wiley eBooks · doi:10.1002/9780470939956.ch18 · Cited by 3
Single Fluorinated Agent for Multiplexed 19F‐MRI with Micromolar Detectability Based on Dynamic Exchange
Shusterman‐Krush, R., Tirukoti, N. D., Bandela, A. K., Avram, L., Allouche‐Arnon, H., Cai, X., Gibb, B. C., & Bar‐Shir, A. (2021) · Angewandte Chemie · doi:10.1002/ange.202100427 · Cited by 2
Effect of Molecular Architecture on the Performance of19F NMR Imaging Agents
Peng, H., Thurecht, K. J., Hsu, S., Blakey, I., Squires, O., Kurniawan, N. D., Rose, S., & Whittaker, A. K. (2011) · ACS symposium series · doi:10.1021/bk-2011-1077.ch028 · Cited by 2
Development of a New Distyrylbenzene-Derivative Amyloid-β-aggregation and Fibril Formation Inhibitor
Suzuki, H., Ishigami, A., Orimoto, A., Matsuyama, A., Handa, S., Maruyama, N., Yokoyama, Y., Okuno, H., & Nakakoshi, M. (2012) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c12-00365 · Cited by 2
Medicen Paris Région, pôle de compétitivité mondial et recherche en neuroscience
Canet, E. (2007) · médecine/sciences · doi:10.1051/medsci/2007234435 · Cited by 2
Highly efficient synthesis of polyfluorinated dendrons suitable for click chemistry
Kölmel, D. K., Nieger, M., & Bräse, S. (2015) · RSC Advances · doi:10.1039/c5ra02804c · Cited by 2
Contrast Agents for Molecular-Level fMRI
Jasanoff, A. (2015) · Biological magnetic resonance · doi:10.1007/978-1-4899-7591-1_29 · Cited by 2
Contrast Agents for Magnetic Resonance Imaging
Jasanoff, A. (2008) · Elsevier eBooks · doi:10.1016/b978-012374212-4.50011-0 · Cited by 2
Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer’s disease
Setti, S. E., Das, N., Raymick, J. B., Hanig, J. P., & Sarkar, S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-021-00885-3 · Cited by 2

Authors: Higuchi, M., Iwata, N., Matsuba, Y., Sato, K., Sasamoto, K., & Saido, T. C.
Affiliations: RIKEN Center for Brain Science (JP)
Corresponding author: Higuchi, Makoto
Saido, Takaomi C
ORCID: Higuchi, Makoto
Iwata, Nobuhisa
Saido, Takaomi C
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2005-03-13
Volume: 8
Issue: 4
Pages: 527-533
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/nn1422
OpenAlex: W1989252530
Cited by: 339
References: 32
Citations by year: 2026: 3 · 2025: 6 · 2024: 9 · 2023: 8 · 2022: 14 · 2021: 14 · 2020: 7 · 2019: 3 · 2018: 15 · 2017: 13 · 2016: 15 · 2015: 16 · 2014: 17 · 2013: 27 · 2012: 15
FWCI: 17.38
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
Funders: RIKEN
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
Keywords: amyloid plaques, Alzheimer's disease, 19F MRI, 1H MRI, amyloid imaging, amyloid precursor protein transgenic mice, non-invasive brain imaging, presymptomatic diagnosis, disease biomarkers
MeSH terms: Age Factors, Alzheimer Disease, Amyloidosis, Animals, Brain, Brain Chemistry, Cell Count, Disease Models, Animal, Dose-Response Relationship, Drug, Fluorescent Dyes, Humans, Immunohistochemistry, Magnetic Resonance Imaging, Memantine, Mice, Transgenic, Phosphopyruvate Hydratase, Radionuclide Imaging, Staining and Labeling, Time Factors, Tritium, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Imaging, Three-Dimensional, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

19F and 1H MRI detection of amyloid β plaques in vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks